Cefaclor Tablet, Film Coated, Extended Release
Product Images NDC 0093-1087

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefaclor (NDC 0093-1087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Cefaclor, showing its core beta-lactam ring with attached side chains, including a chlorine-substituted thiazole ring and a hydrated form (H2O).*

FDA Label Image

Image 2

Label for Cefaclor Extended-Release Tablets USP 500 mg, film-coated oral tablets. The label indicates a package size of 100 tablets and lists Teva Pharmaceuticals USA, Inc. as the labeler. The NDC code shown is 0093-1087-01, with instructions to not cut or crush the tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.